Temporal and spatial stability of the EM/PM molecular subtypes in adult diffuse glioma
暂无分享,去创建一个
F. Tang | Tao Jiang | Kai Yu | Yingyu Sun | Zhiyan Sun | Zheng Zhao | Z. Bao | Wei Zhang | Xiaolong Fan | Guanzhang Li | Chuan Fang | X. Qi | Yanli Tan | Jing Feng | Z. Duan | Jun Yang | Jiuyi Li | Xiao-Ming Su | Fan Wu | Yanfei Wei | Yunqiu Zhang | Zhengmin Cong | Yaxin Wang | Fuchou Tang
[1] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[2] Anna Luisa Di Stefano,et al. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities , 2021, Nature Cancer.
[3] S. Bicciato,et al. Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in Glioblastoma , 2020, Nature Cancer.
[4] G. Reifenberger,et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood , 2020, Nature Reviews Clinical Oncology.
[5] F. Tang,et al. Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies , 2020, National science review.
[6] Chao Yang,et al. Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas , 2019, Aging.
[7] Jeffrey H. Chuang,et al. LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS , 2019, Nature.
[8] Mariella G. Filbin,et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma , 2019, Cell.
[9] Ash A. Alizadeh,et al. Determining cell-type abundance and expression from bulk tissues with digital cytometry , 2019, Nature Biotechnology.
[10] Z. Wang,et al. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma , 2019, Proceedings of the National Academy of Sciences.
[11] D. Burns,et al. Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction , 2019, Nature Neuroscience.
[12] Giles W. Robinson,et al. Challenges to curing primary brain tumours , 2019, Nature Reviews Clinical Oncology.
[13] P. Sims,et al. Single-Cell Analysis of Regional Differences in Adult V-SVZ Neural Stem Cell Lineages , 2019, Cell reports.
[14] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[15] M. Ceccarelli,et al. Single-cell transcriptome analysis of lineage diversity in high-grade glioma , 2018, Genome Medicine.
[16] B. Deneen,et al. A glial blueprint for gliomagenesis , 2018, Nature Reviews Neuroscience.
[17] Fuhui Long,et al. An anatomic transcriptional atlas of human glioblastoma , 2018, Science.
[18] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[19] Arul M. Chinnaiyan,et al. Cancer transcriptome profiling at the juncture of clinical translation , 2017, Nature Reviews Genetics.
[20] Steven D Chang,et al. Single-Cell RNAseq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma , 2017, bioRxiv.
[21] Edward F. Chang,et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.
[22] K. Ligon,et al. Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] C. Vorhees,et al. Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior , 2017, Cell reports.
[24] In-Hee Lee,et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma , 2017, Nature Genetics.
[25] Mariella G. Filbin,et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq , 2017, Science.
[26] L. Parada,et al. Cell of origin of glioma: biological and clinical implications , 2016, British Journal of Cancer.
[27] Mariella G. Filbin,et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma , 2016, Nature.
[28] F. Doetsch,et al. A mosaic world: puzzles revealed by adult neural stem cell heterogeneity , 2016, Wiley interdisciplinary reviews. Developmental biology.
[29] Jens Hjerling-Leffler,et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system , 2016, Science.
[30] In-Hee Lee,et al. Clonal evolution of glioblastoma under therapy , 2016, Nature Genetics.
[31] G. Reifenberger,et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.
[32] D. Bergles,et al. Electrophysiological properties of NG2+ cells: Matching physiological studies with gene expression profiles , 2016, Brain Research.
[33] Eric Talevich,et al. CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..
[34] F. C. Bennett,et al. New tools for studying microglia in the mouse and human CNS , 2016, Proceedings of the National Academy of Sciences.
[35] Steven J. M. Jones,et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.
[36] S. Kwon,et al. Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance , 2015, PloS one.
[37] In-Hee Lee,et al. Spatiotemporal Evolution of the Primary Glioblastoma Genome. , 2015, Cancer cell.
[38] Satoru Miyano,et al. Mutational landscape and clonal architecture in grade II and III gliomas , 2015, Nature Genetics.
[39] Jill S Barnholtz-Sloan,et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution , 2015, Genome research.
[40] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[41] Charlotte Soneson,et al. A glioma classification scheme based on coexpression modules of EGFR and PDGFRA , 2014, Proceedings of the National Academy of Sciences.
[42] Steven J. M. Jones,et al. Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma , 2014, Science.
[43] David E Larson,et al. Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection , 2013, Current protocols in bioinformatics.
[44] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[45] H. Woo,et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. , 2013, Cell reports.
[46] Lynda Chin,et al. Emerging insights into the molecular and cellular basis of glioblastoma. , 2012, Genes & development.
[47] Debyani Chakravarty,et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response , 2012, Proceedings of the National Academy of Sciences.
[48] Rebecca A Betensky,et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. , 2011, Cancer cell.
[49] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[50] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[51] Erika Pastrana,et al. Simultaneous prospective purification of adult subventricular zone neural stem cells and their progeny , 2009, Proceedings of the National Academy of Sciences.
[52] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[53] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[54] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[55] J. Mesirov,et al. Metagene projection for cross-platform, cross-species characterization of global transcriptional states , 2007, Proceedings of the National Academy of Sciences.
[56] W. Sellers,et al. Lineage dependency and lineage-survival oncogenes in human cancer , 2006, Nature Reviews Cancer.
[57] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.